[ad_1]
PHILADELPHIA (June 12, 2019) – In order to reduce the number of people who may be misusing, abusive or excessive use of opioids, several national agencies, including the Centers for Disease Control and Prevention (CDC), have published guidelines to improve the way opioids are prescribed. However, some of these guidelines have led to confusion and misapplication among clinicians and have unintentionally limited the treatment of pain in people with cancer.
A JAMA Oncology An article by two Penn researchers calling for uniformity of clinical practice guidelines for pain control in people with cancer-related pain has helped narrow the gap between the management guidelines of the pain. As a result, the CDC has published key clarifications on its guideline for opioid prescription for chronic pain in order to ensure safe and appropriate access to cancer patients, cancer survivors and patients. people with sickle cell disease. The clarification of the CDC is particularly important because many insurance payers use it inappropriately to determine opioid coverage for these specific populations.
"Many of the current recommendations regarding opioid prescribing practices stem from a consensus of experts rather than empirical research, which is urgently needed to develop and develop Informed guidelines for patients with chronic cancer-related pain, "said Salimah H. Meghani, lead author of the article, Penn Nursing. , PhD, MBE, RN, FAAN, Associate Professor of Nursing and Chair in Palliative Care Long Term Care; Associate Director, NewCourtland Center for Transitions and Health; and Principal Investigator at the Leonard Davis Institute of Health Economics.
###
The article was co-authored by Neha Vapiwala, MD, Associate Professor of Radiation Oncology and Vice President of the Chair of Education at the Perelman School of Medicine at the University of Pennsylvania (PSOM). Both authors played an important role in the meeting with the CDC, the National Comprehensive Cancer Network® (NCCN®), the American Society of Clinical Oncology (ASCO), the Food and Drug Administration, and others. leading stakeholders, which clarified this key policy.
About the School of Nursing at the University of Pennsylvania
The University of Pennsylvania School of Nursing is one of the world's leading schools of nursing. For the fourth year in a row, it is ranked No. 1 of the world's nursing schools by QS University and consistently ranks high on the annual list of the best graduate schools in the United States. Penn Nursing is currently ranked # 1 for funding by the National Institutes of Health, among other schools of nursing, for the second year in a row. Penn Nursing prepares scientific nurses and nurse leaders to meet the global health needs of society by innovating in the areas of research, education, and practice. Follow Penn Nursing on: Facebook, Twitter, LinkedIn and Instagram.
Warning: AAAS and EurekAlert! are not responsible for the accuracy of the news releases published on EurekAlert! contributing institutions or for the use of any information via the EurekAlert system.
Source link
